Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Four-drug combo therapy shows benefit for newly-diagnosed myeloma patients

pharmatimesJuly 27, 2021

Tag: ICR , carfilzomib , Lenalidomide , KRdc , myeloma

PharmaSources Customer Service